A large study of immediate versus deferred antiretroviral treatment in South African infants has found a significant advantage to immediate treatment after just eight months of follow-up, and researchers monitoring the trial have decided that the `deferred treatment` arm of the study should be closed and all children not yet receiving treatment should be evaluated to determine whether they should start antiretroviral therapy.